Your browser doesn't support javascript.
loading
Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinoma.
Jiang, Jun; Lu, Yuan; Zhang, Fang; Pan, Tao; Zhang, Zhipei; Wan, Yi; Ren, Xinling; Zhang, Rui.
Afiliação
  • Jiang J; Department of Health Service, Base of Health Service, Fourth Military Medical University, Xi'an, China.
  • Lu Y; Department of Respiratory and Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing, China.
  • Zhang F; Department of Respiratory and Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Pan T; Department of Respiratory and Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Zhang Z; Translational Medicine Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Wan Y; Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
  • Ren X; Department of Health Service, Base of Health Service, Fourth Military Medical University, Xi'an, China.
  • Zhang R; Department of Respiratory and Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China. majrenxl@fmmu.edu.cn.
BMC Cancer ; 22(1): 632, 2022 Jun 08.
Article em En | MEDLINE | ID: mdl-35676688

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Semaforinas / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Semaforinas / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China